Michael Raab
Director; Director, President & CEO · 12 filings · Latest: Aug 21, 2026
AMICUS THERAPEUTICS, INC.
ARDELYX, INC.
Tempest Therapeutics, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
ARDX | RAAB MICHAEL | — | Feb 20, 2026 | Proposed Sale | $5.73 | 51,100 | $292.8K | — | |
ARDX | RAAB MICHAEL | — | Nov 20, 2025 | Proposed Sale | $5.91 | 45,868 | $271.1K | — | |
ARDX | MICHAEL RAAB | — | May 2, 2025 | Proposed Sale | $5.47 | 125,000 | $683.8K | — | |
ARDX | MICHAEL RAAB | — | Jan 7, 2025 | Proposed Sale | $5.00 | 166,666 | $833.3K | — | |
ARDX | MICHAEL G. RAAB | — | Dec 10, 2024 | Proposed Sale | $5.26 | 25,000 | $131.6K | — | |
ARDX | MICHAEL G. RAAB | — | Nov 25, 2024 | Proposed Sale | $5.38 | 25,000 | $134.5K | — | |
ARDX | MICHAEL G. RAAB | — | Nov 11, 2024 | Proposed Sale | $4.90 | 2,743 | $13.4K | — | |
ARDX | MICHAEL G. RAAB | — | Oct 28, 2024 | Proposed Sale | $5.91 | 25,000 | $147.7K | — | |
ARDX | MICHAEL G. RAAB | — | Oct 11, 2024 | Proposed Sale | $6.01 | 7,500 | $45.1K | — | |
ARDX | MICHAEL G. RAAB | — | Sep 26, 2024 | Proposed Sale | $6.07 | 3,000 | $18.2K | — | |
ARDX | MICHAEL G. RAAB | — | Sep 11, 2024 | Proposed Sale | $5.61 | 35,000 | $196.4K | — | |
ARDX | MICHAEL G. RAAB | — | Aug 27, 2024 | Proposed Sale | $6.22 | 7,500 | $46.6K | — |
← Previous
Page 2 of 2